STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

INCY INCYTE CORPORATION StockScouter® Report

7

StockScouter® Score

INCYTE CORPORATION, a mid cap growth company in the healthcare sector, is expected to outperform the market over the next six months with slightly less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
  • The multi-period measure of relative price change and consistency is well above average. Positive

 

Concerns

  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
  • An executive, director or major shareholder sold a large number of shares recently. Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be out of favor, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 40% done.
Progress: 100% done.
Low
High

Core Model Grades

B
D
C
A

Previous Ratings

7
8
7